a b s t r a c t Paediatric aneurysms are rare and represent the end result of a variety of different pathological mechanisms. They have a varied presentation and features that are distinct from their adult counterparts. The appropriate management of these aneurysms requires a multi-disciplinary team approach and detailed analysis to deal with the underlying pathology. This can involve the use of coils, adjunctive devices such as neck-bridging devices, flow diverters and liquid embolic agents, as well as microsurgical clipping. In this paper we discuss the different types of aneurysms that can present in the paediatric population and present cases that highlight the entire spectrum of paediatric aneurysmal disease and the different treatment options currently available. Treatment of paediatric intracranial aneurysms requires individualized strategies.
Introduction
Intracranial aneurysms in the paediatric population are relatively uncommon and occur less frequently than in adults, accounting for <5% of all intracranial aneurysms [1, 2] . Although in the adult population various risk factors can contribute to the formation of aneurysms these are unlikely to contribute to the formation aneurysms in the paediatric population. Compared to adults there are differences in aneurysm location, morphological characteristics, presentation and outcome. The treatment of aneurysms in the adult population underwent considerable changes since the publication of the International Subarachnoid Aneurysm Trial (ISAT) [3] , with endovascular coiling showing advantages over microsurgical clipping. However, there has been no such trial in the paediatric population and it is unlikely that there ever will be. The published literature consists of case series [4] [5] [6] [7] [8] [9] , however, even the available literature is scarce compared to the published material on adult aneurysms.
We sought to describe our experience of treating paediatric aneurysms using a variety of different endovascular strategies and highlight the potential advantages and disadvantages of the different strategies.
Saccular aneurysms
Classic saccular or berry aneurysms are rarely seen in neonates, infants and children below the age of 10, however, their incidence increases with age and up to 20% of aneurysms seen in those below 18 years old may be classified as saccular aneurysms [10] [11] [12] . Although the underlying patho-mechanisms involved in the formation of these aneurysms in children may differ compared to adults some authors believe that the treatment and natural history of classical saccular aneurysms does not significantly differ from that in adults [10] . In this regard both microsurgical and endovascular treatment options ( Fig. 1) can play a valuable role in the management of these aneurysms. Consistent with adult aneurysm management and the shift towards endovascular concepts there has been a gradual increase in the use of the endovascular techniques compared to microsurgical clipping since the publication of ISAT, with approximately 50% of paediatric aneurysms treated endovascularly according to Beez et al. [13] .
Dissecting and fusiform aneurysms
Dissecting and fusiform aneurysms are over represented in the paediatric population in comparison to adults, with Krings et al. [10] reporting that the incidence of dissecting aneurysms in the paediatric population is four times higher than in the adult population. This group also suggests that up to 50% of all aneurysms in the paediatric population, particularly in younger infants and children, may be the result of a dissection. As with dissecting aneurysms in the adult the presentation can be extremely varied and a high degree of suspicion and prompt thorough investigation is required in order to accurately identify the underlying pathology. The presenting symptoms can be related to ischaemia, subarachnoid haemorrhage or mass effect and in certain circumstances a combination of different symptoms. Dissections that present with subarachnoid haemorrhage have a predisposition for recurrent haemorrhage and this risk is highest in the early post-ictal period with up to 80% of recurrent haemorrhages occurring during the first week [14, 15] . As in adults there are several treatment options available for dissecting aneurysms and these can be broadly classified as reconstructive (parent artery preserving) (Figs. 2 and 3 ) or deconstructive (parent artery sacrificing) (Fig. 4) . The decision on which treatment option is most suitable will be determined by a variety of factors such as exact location of the dissection, presence of collateral supply, local perforator arteries, etc. The recent development of flow diverting stents has provided a viable treatment option for dissecting aneurysms. The tightly woven mesh of these stents will act to not only redirect blood away from the dissection but also tack the dissection flap down against the arterial wall. The implantation of these devices requires the usage of dual antiplatelet agents, which may increase the risk of re-haemorrhage. In addition to the risks of anti-platelet agents the long-term results of the device implantation in the paediatric population are not known. More recently coated flow diverters, such as the Pipeline Shield (Medtronic) have become available which may not require dual anti-platelet agents. If vessel sacrifice is considered then parent vessel occlusion with coils is a suitable treatment option. Prior to parent vessel occlusion balloon test occlusion with analysis of the collateral supply should be performed and although the pial collaterals in children are usually sufficient to allow for vessel sacrifice, this strategy could require a conjunctive bypass operation.
Chronic dissections may result in fusiform aneurysms. In this scenario some authors follow a conservative strategy with close follow-up [10] , however, an alternative is parent artery reconstruction with flow diversion. Several case reports and case series have reported on the use of flow diverters in the paediatric population [16] [17] [18] [19] [20] [21] [22] and these have shown, as in adults, gradual occlusion of the aneurysms over time. However, the use of flow diverters or intracranial stents in children needs to be considered carefully. The first issue is that of the child's growth and the expected change in the size of the cerebral vessels might be considered as a contradiction to the use of flow diverters or stents in general [16, 23, 24] . However, it has been shown that the cranial growth is rapid during the early years of life and then slows markedly with virtual complete growth by the age of 6 years with 85% of growth complete by the age of 5 [25] . Similarly, by the age of 4 years the intracranial arteries have reached 81-99% of their adult diameters with 87% of the middle cerebral artery (MCA) diameter reached by 6 months of age [26] . Similar findings were reported by He et al. [27] who dubbed it 'the rule of 5' since the vast majority of the arterial growth occurs before the age of 5. The second issue, and much more important, is that of anti-platelet medication. There are currently no available guidelines on the use of anti-platelet agents in children with cerebrovascular diseases and no definite Fig. 1 . A 13-year-old boy with a previously diagnosed hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) sustained a massive right frontal intracerebral and subarachnoid haemorrhage, which required decompressive craniectomy. DSA showed a cerebellar AVM and a large right frontal brain AVM with a flow related aneurysm at the right MCA bifurcation (a and b). The aneurysm was the likely source of the intracranial haemorrhage. This aneurysm was wide necked and showed an irregular shape. A significant risk of recurrent haemorrhage was anticipated. After a thorough interdisciplinary discussion, taking haematological, paediatric, surgical and endovascular aspects into account, a pCONus2_HPC neck-bridging device was implanted (c). This version of the pCONus device has a hydrophilic surface with reduced thrombogenicity and therefore requires the patient to be placed only on ASA and not on dual anti-platelet medication. After placement of the pCONus2_HPC the aneurysm was coiled (d) and completely occluded (e and f). The patient was initially started on ASA and Clopidogrel. Three weeks after the treatment recurrent epistaxis prompted a reduction of the platelet function inhibition, which was continued with 50 mg ASA PO daily, without thrombosis of the bifurcation implant pCONus2_HPC.
anti-platelet regimes [23] . This difficulty in dosing is compounded by the difficulties of ensuring the continued use of anti-platelet agent use throughout life, the need to adjust the dose periodically as well as other issues such as the American Heart Association advice that aspirin be withheld in children with influenza or chicken pox infections [28] . The dosing of clopidogrel in the paediatric population was established after the results of the PICOLO trial [29] . This study identified the lower limit of titration as 0.2 mg/kg/day and this dose showed a 43.9% platelet aggregation inhibition, which is comparable to the degree of platelet aggregation inhibition in adults (40-60% with the standard loading dose of 300 mg followed by 75 mg per day). We use a body weight adapted dosage with 2 mg ASA and 1 mg Clopidogrel per kilogram as initial dosage for several days, followed by repeated response tests. Since 2002 we use the Multiplate Analyzer (Roche Diagnostics) and since 2015 in addition the VerifyNow test (Accumetrics). Prior to any stent-or flow diverter implantation, adequate platelet inhibition is confirmed in every patient. In the case of hyporesponse, the dosage is either increased or the medication is changed to Ticagrelor. In patients with hyper-response, a gradual dosage reduction is applied aiming at an appropriate level of platelet inhibition. We identified 12 cases that used the Pipeline Embolisation Device (PED) in paediatric patients [16, 18, [30] [31] [32] [33] [34] . Of these cases two patients experienced thrombotic complications including one case with an asymptomatic parent vessel occlusion and one case of haemorrhagic complication [30] .
Infectious aneurysms
Approximately 15% of all paediatric aneurysms are believed to be secondary to an infection. The most common bacterial pathogen involved in intracranial cerebral aneurysms is Staphylococcus aureus followed by Streptococcus viridans and other gram negative bacteria [35] . In up to 1/3 of cases the causative organism is not found on examination of the blood and CSF. There are currently thought to be two patho-mechanisms involved in the formation of the aneurysms. In the distal arteries it is thought that the infection spreads from the lumen to the extravascular space as septic emboli, which damages the endothelium. In larger arteries the infection may spread directly from adjacent structures such as an osteomyelitis of the bone. Naturally septic emboli affecting the vaso vasorum can also occur in the larger vessels [36] [37] [38] . In both Fig. 3 . A 5-year-old girl was jumping on her bed when she fell down. Initially she was asymptomatic after the fall, however, after several hours she became increasingly somnolent. An MRI performed at her local hospital showed a suspected dissecting aneurysm of the proximal basilar artery. She was transferred to the local neurosurgical centre where a repeat CT and CT angiography confirmed sub-arachnoid and intra-ventricular haemorrhage (a). An endo-ventricular drain was placed. The next day she underwent catheter angiography, which confirmed the findings on the CTA (b) followed by treatment which consisted of endoluminal flow diversion with two p64 flow diverting stents and one Pipeline Shield flow diverter deployed telescopically from the left vertebral artery into the mid-basilar artery (c). After deployment of the flowdiverting stents there was marked contrast stagnation within the pseudoaneurysm. Given the location of the pseudoaneurysm, occlusion of the contralateral vertebral artery was performed in order to prevent an endoleak around the flow diverter construct. The patient was loaded with 25 mg aspirin intravenously and 90 mg ticagrelor per oral on the morning of the procedure. The patient will be continued on 1Â 50 mg aspirin per day and 2Â 45 mg ticagrelor per day. Fig. 2 . A 14-year-old female patient was found to have an incidental fusiform dissecting aneurysm of the left M1 segment (a-c). After a multi-disciplinary team discussion with the child and family it was decided to treat the aneurysm with 3 telescoping flow diverter stents (d). There were no immediate complications and follow-up angiography 6 weeks later showed no filling of the aneurysm (f). Although anterograde flow into the left A1 segment could not be seen the anterior cerebral artery territory was adequately supplied from the right A1 segment (e). Fig. 4 . An 11-year-old patient was admitted with acute haemorrhage centred on the right basal ganglia (a). There were no other medical problems. Angiography revealed a small aneurysm arising from a distal branch of a medial lenticulostriate artery (b, white arrow). There was no evidence of an underlying associated vascular malformation and the aneurysm was thought to represent a dissecting type pseudoaneurysm. Proximal parent vessel occlusion was achieved using 2 small coils (c). There were no complications. Fig. 5 . A 17-year-old female patient with endocarditis presented to the emergency department with acute headache and left sided motor weakness. A CT scan showed a right fronto-parietal intra-parenchymal haemorrhage (a) and hyperdensity in the left Sylvian fissure (b). Angiography confirmed the presence of an aneurysm arising from a M2 branch of the left middle cerebral artery (MCA) that correlated with the hyperdensity seen on the CT scan (c, white arrow). After a multi-disciplinary team discussion it was decided to treat the aneurysm. Under general anaesthesia a microcatheter was introduced in the aneurysm. Asystole (20 s) was induced using a 36 mg IV bolus injection of adenosine and during this a 1:1 ratio of Glubran2 + lipiodol was injected to fill the aneurysm and prevent distal glue migration (d and e). There were no complications and 6 week follow-up MRI did not show any growth of the aneurysm nor signs of infarction.
scenarios the primary affect is on the adventitia, with the intima and media being secondarily involved. These aneurysms can be multiple and this is especially true in patients that are immunecompromised. Infectious aneurysms will often present with either subarachnoid or intracerebral haemorrhage. Their fragile nature makes them prone to re-rupture and therefore the treatment strategy is two-fold -treat the ruptured aneurysm and concomitantly initiate treatment against the source of the infection. However, given the underlying pathomechanism the implantation of metallic devices such as coils should be avoided. Furthermore, as the aneurysms are extremely fragile they can be easily ruptured during coil deployment similar to dissecting pseudoaneurysms. For this reason liquid embolics are suitable agents to treat ruptured infectious aneurysms. Glue can be used to obliterate the aneurysmal sac or alternatively it can be used to occlude the parent vessel (Fig. 5 ).
Giant aneurysms
Giant aneurysms (>25 mm) are seen much more commonly in children compared to adults with 38% of aneurysms in the systematic review of Beez et al. [13] being giant. These aneurysms can be partially thrombosed, which may be seen as variable T1 hyperintensity in the aneurysmal sac on MR imaging. Giant aneurysms tend present with mass effect on nearby structures and therefore, the treatment of these aneurysms must also target the mass effect. Dense coiling of the actual aneurysm sac may not relieve the mass effect. Furthermore, if there is considerable intra-aneurysmal thrombus then the coils can disperse into the thrombus and result in aneurysmal recurrence and the need for repeated treatments. Similarly if the aneurysm is the consequence of a dissecting process then coil occlusion of the aneurysm will not deal with the underlying pathology. For these reasons both parent vessel occlusion (Fig. 6 ) and flow diversion should be considered. These aneurysms can be the most difficult to treat since they can recur even after parent vessel occlusion [39] .
Conclusion
Paediatric intracranial aneurysms are a rare disease that can arise from a variety of different underlying pathological mechanisms. The management of these conditions requires a detailed understanding of the pathology and a multi-disciplinary approach in order to institute the correct treatment strategy. Although many of the strategies documented in this series are 'off-label', the technical challenges of setting up and complete an appropriately powered and structured randomised controlled trial mean it is unlikely that this level of evidence will become available. It is also extremely unlikely that data for all new devices would become available specifically for the paediatric population. Therefore, we believe it is important that case series and innovative techniques are presented and published so as to expand the body of evidence and assist optimising treatment strategies for this group of patients.
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HH is a co-founder and shareholder of phenox GmbH. The other authors have no potential conflict of interest. . A 6 month old girl, previous healthy, presented after her mother noticed an abnormality in the right eye, which on examination was shown to be an oculomotor nerve palsy. A CT scan of the head revealed an abnormality in the region of the cavernous sinus on the right and a CT angiogram confirmed the suspicion of a giant aneurysm likely secondary to dysplastic cavernous and ophthalmic segments of the ICA. After a balloon test occlusion had shown sufficient supply of the right anterior circulation via the AcomA, coil occlusion of the artery was performed. There were no intra-operative or post-operative complications and the patient developed normally.
